A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease.

Clin Epigenetics · 2021 · PMC8360816 · PMID 34389043

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

a positive trendp = 0.09so close (0.05 < p ≤ 0.1)

Although we observed a positive trend between PON1 expression level and lactonase activity ( p = 0.09; EE = 1.23 change in lactonase activity in relation to increased expression; STDE = 0.7059), no direct relationship between relative expression and arylesterase activity was determined ( p = 0.124; EE = 1.32; STDE = 0.8173).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.